- The company and all members of the board guarantee that the content of the information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Securities Code: 301089
Securities Abbreviation: Tuo Xin Pharmaceutical
Announcement Number: 2026-022
Tuo Xin Pharmaceutical Group Co., Ltd.
Announcement of Resolutions from the 2025 Annual Shareholders' Meeting
Special Note:
- There were no rejected proposals during this shareholders' meeting.
- This shareholders' meeting did not involve changes to resolutions previously approved by past meetings.
I. Meeting Time and Attendance
(1) Meeting Time:
- On-site meeting time: April 23, 2026 (Thursday) at 9:00 AM
- Online voting time: The time for online voting through the Shenzhen Stock Exchange trading system is during trading hours on April 23, 2026, specifically from 9:15-9:25, 9:30-11:30, and 1:00-3:00 PM; the specific time for voting through the Shenzhen Stock Exchange Internet voting system is any time between 9:15 AM and 3:00 PM on April 23, 2026.
(2) Meeting Location: Conference Room of Tuo Xin Pharmaceutical Group Co., Ltd.
(3) Meeting Method: A combination of on-site voting and online voting.
(4) Meeting Convener: The company's board of directors.
(5) Meeting Host: Mr. Yang Shaohua, elected by a majority of directors, hosted the meeting.
(6) The convening, holding, and voting methods of this shareholders' meeting comply with the relevant laws, administrative regulations, departmental rules, normative documents, and the Articles of Association of Tuo Xin Pharmaceutical Group Co., Ltd.
(7) Attendance: - Total attendance of shareholders: 100 shareholders participated through on-site and online voting, representing 63,066,032 shares, accounting for 49.8370% of the total shares with voting rights. Among them: 3 shareholders voted on-site, representing 40,082,550 shares (31.6747%); 97 shareholders voted online, representing 22,983,482 shares (18.1624%).
- Attendance of small and medium shareholders: 94 small and medium shareholders participated through on-site and online voting, representing 369,300 shares (0.2918%).
- Other attendees: Company directors and senior management attended the meeting in person and via video. Witnessing lawyers were present at the meeting.
II. Proposal Review and Voting Results
This shareholders' meeting adopted a combination of on-site and online voting to vote on the following proposals:
- Review and approval of the proposal on the "2025 Annual Report" and its summary:
| Vote Type | Shares Voted | Percentage |
|-----------|--------------|------------|
| Agree | 62,903,132 | 99.7417% |
| Oppose | 154,400 | 0.2448% |
| Abstain | 8,500 | 0.0135% |
Among them, the total voting situation of small and medium shareholders:
| Vote Type | Shares Voted | Percentage |
|---|---|---|
| Agree | 206,400 | 55.8895% |
| Oppose | 154,400 | 41.8088% |
| Abstain | 8,500 | 2.3017% |
-
Review and approval of the proposal on the "2025 Board of Directors Work Report":
Vote Type Shares Voted Percentage Agree 62,903,132 99.7417% Oppose 154,400 0.2448% Abstain 8,500 0.0135% -
Review and approval of the proposal on the "2025 Financial Settlement Report":
Vote Type Shares Voted Percentage Agree 62,903,132 99.7417% Oppose 154,400 0.2448% Abstain 8,500 0.0135%